204 related articles for article (PubMed ID: 3028398)
1. Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.
Baba M; Pauwels R; Herdewijn P; De Clercq E; Desmyter J; Vandeputte M
Biochem Biophys Res Commun; 1987 Jan; 142(1):128-34. PubMed ID: 3028398
[TBL] [Abstract][Full Text] [Related]
2. 3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents.
Herdewijn P; Balzarini J; De Clercq E; Pauwels R; Baba M; Broder S; Vanderhaeghe H
J Med Chem; 1987 Aug; 30(8):1270-8. PubMed ID: 3497272
[TBL] [Abstract][Full Text] [Related]
3. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
Balzarini J; Kang GJ; Dalal M; Herdewijn P; De Clercq E; Broder S; Johns DG
Mol Pharmacol; 1987 Jul; 32(1):162-7. PubMed ID: 3648476
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
Hamamoto Y; Nakashima H; Matsui T; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1987 Jun; 31(6):907-10. PubMed ID: 3039911
[TBL] [Abstract][Full Text] [Related]
5. Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus.
Pauwels R; De Clercq E; Desmyter J; Balzarini J; Goubau P; Herdewijn P; Vanderhaeghe H; Vandeputte M
J Virol Methods; 1987 Jun; 16(3):171-85. PubMed ID: 2821048
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides.
Herdewijn P; Balzarini J; Baba M; Pauwels R; Van Aerschot A; Janssen G; De Clercq E
J Med Chem; 1988 Oct; 31(10):2040-8. PubMed ID: 3172142
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine.
Matthes E; Lehmann C; Scholz D; Rosenthal HA; Langen P
Biochem Biophys Res Commun; 1988 Jun; 153(2):825-31. PubMed ID: 3164184
[TBL] [Abstract][Full Text] [Related]
8. Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.
Balzarini J; Herdewijn P; De Clercq E
J Biol Chem; 1989 Apr; 264(11):6127-33. PubMed ID: 2539371
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Broder S
AIDS Res Hum Retroviruses; 1988 Apr; 4(2):107-13. PubMed ID: 2835072
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro.
Baba M; Pauwels R; Balzarini J; Herdewijn P; De Clercq E
Biochem Biophys Res Commun; 1987 Jun; 145(3):1080-6. PubMed ID: 3649230
[TBL] [Abstract][Full Text] [Related]
11. Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues.
Balzarini J; Baba M; Pauwels R; Herdewijn P; De Clerq E
Biochem Pharmacol; 1988 Jul; 37(14):2847-56. PubMed ID: 2840080
[TBL] [Abstract][Full Text] [Related]
12. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
Nakashima H; Tochikura T; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083
[TBL] [Abstract][Full Text] [Related]
13. Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine.
Balzarini J; Pauwels R; Herdewijn P; De Clercq E; Cooney DA; Kang GJ; Dalal M; Johns DG; Broder S
Biochem Biophys Res Commun; 1986 Oct; 140(2):735-42. PubMed ID: 3022729
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiretrovirus effects, and phosphorylation kinetics of 3'-isocyano-3'-deoxythymidine and 3'-isocyano-2',3'-dideoxyuridine.
Hiebl J; Zbiral E; Balzarini J; De Clercq E
J Med Chem; 1990 Feb; 33(2):845-8. PubMed ID: 2299647
[TBL] [Abstract][Full Text] [Related]
15. Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1.
Richman DD
Antimicrob Agents Chemother; 1987 Dec; 31(12):1879-81. PubMed ID: 3501941
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
[TBL] [Abstract][Full Text] [Related]
17. Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro.
Vince R; Hua M; Brownell J; Daluge S; Lee FC; Shannon WM; Lavelle GC; Qualls J; Weislow OS; Kiser R
Biochem Biophys Res Commun; 1988 Oct; 156(2):1046-53. PubMed ID: 2847711
[TBL] [Abstract][Full Text] [Related]
18. Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro.
Baba M; Pauwels R; Balzarini J; Herdewijn P; De Clercq E; Desmyter J
Antimicrob Agents Chemother; 1987 Oct; 31(10):1613-7. PubMed ID: 3435108
[TBL] [Abstract][Full Text] [Related]
19. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
Hao Z; Cooney DA; Hartman NR; Perno CF; Fridland A; DeVico AL; Sarngadharan MG; Broder S; Johns DG
Mol Pharmacol; 1988 Oct; 34(4):431-5. PubMed ID: 2459590
[TBL] [Abstract][Full Text] [Related]
20. Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus.
Lin TS; Schinazi RF; Prusoff WH
Biochem Pharmacol; 1987 Sep; 36(17):2713-8. PubMed ID: 2443141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
